Portfolio of other investment areas
As of the end of September 2011, our technology portfolio comprised 18 portfolio companies and our life science portfolio 10 companies. Our teams are now focusing on developing these portfolio companies with aggregate net sales of €492 million and approx. 5,300 employees (2010 figures).
Please click the company names below for more information.
